Group One Trading
XFOR icon

Group One Trading’s X4 Pharmaceuticals XFOR Stock Holding History

Group One Trading’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-184,100
Closed -$736K – 8907
2025
Q4 		$736K Sell
184,100
-8,800
-5% -$32K ﹤0.01% 3171
2025
Q3 		$660K Sell
192,900
-67,800
-26% -$175K ﹤0.01% 3426
2025
Q2 		$495K Buy
260,700
+249,807
+2,293% +$1.02M ﹤0.01% 3432
2025
Q1 		$77.3K Buy
10,893
+3,816
+54% +$52.6K ﹤0.01% 4808
2024
Q4 		$156K Buy
7,077
+1,057
+18% +$16.8K ﹤0.01% 4132
2024
Q3 		$121K Buy
6,020
+657
+12% +$13.7K ﹤0.01% 4016
2024
Q2 		$93.3K Buy
5,363
+3,363
+168% +$110K ﹤0.01% 4015
2024
Q1 		$83.4K Sell
2,000
-2,337
-54% -$65K ﹤0.01% 4301
2023
Q4 		$109K Sell
4,337
-1,450
-25% -$35.3K ﹤0.01% 4385
2023
Q3 		$189K Sell
5,787
-220
-4% -$9.6K ﹤0.01% 3850
2023
Q2 		$350K Buy
6,007
+5,850
+3,726% +$301K ﹤0.01% 3389
2023
Q1 		$4.09K Sell
157
-300
-66% -$8.8K ﹤0.01% 6366
2022
Q4 		$13.6K Buy
457
+367
+408% +$17.4K ﹤0.01% 5859
2022
Q3 		$5K Sell
90
-3,903
-98% -$135K ﹤0.01% 6861
2022
Q2 		$116K Buy
3,993
+6
+0.2% +$228 ﹤0.01% 4844
2022
Q1 		$209K Buy
3,987
+3,617
+978% +$207K ﹤0.01% 4755
2021
Q4 		$25K Buy
370
+327
+760% +$41.4K ﹤0.01% 6846
2021
Q3 		$7K Buy
+43
New +$7.08K ﹤0.01% 7654

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's XFOR Position: Q2 2026 in Review

Group One Trading held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 712 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #6885.

Group One Trading first reported a position in XFOR in Q3 2021 and has held it in 19 quarters since. The position peaked at $632K in Q2 2023. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Group One Trading held 712 shares of X4 Pharmaceuticals worth $3.33K as of Q2 2026.
  • Group One Trading left its X4 Pharmaceuticals share count unchanged in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6885 holding.
  • Group One Trading first reported a position in X4 Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Group One Trading's X4 Pharmaceuticals position peaked at $632K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.